Compassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)

NCT00419367 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Lymphoma, T-Cell, Cutaneous

Interventions

DRUG: Comparator: vorinostat

Sponsor

Merck Sharp & Dohme LLC